Congress Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.2M | Buy |
141,370
+34,488
| +32% | +$6.4M | 0.25% | 94 |
|
|
2025
Q1 | $22.4M | Buy |
106,882
+9,338
| +10% | +$1.96M | 0.27% | 95 |
|
|
2024
Q4 | $17.3M | Sell |
97,544
-93,697
| -49% | -$16.7M | 0.24% | 122 |
|
|
2024
Q3 | $37.8M | Buy |
191,241
+24,260
| +15% | +$4.79M | 0.5% | 44 |
|
|
2024
Q2 | $28.6M | Buy |
166,981
+52,161
| +45% | +$8.95M | 0.46% | 47 |
|
|
2024
Q1 | $20.9M | Sell |
114,820
-10,187
| -8% | -$1.86M | 0.36% | 66 |
|
|
2023
Q4 | $19.4M | Buy |
125,007
+21,464
| +21% | +$3.33M | 0.36% | 64 |
|
|
2023
Q3 | $15.4M | Buy |
103,543
+4,199
| +4% | +$626K | 0.32% | 71 |
|
|
2023
Q2 | $13.4M | Buy |
99,344
+1,242
| +1% | +$167K | 0.31% | 86 |
|
|
2023
Q1 | $15.6M | Buy |
98,102
+1,217
| +1% | +$194K | 0.38% | 59 |
|
|
2022
Q4 | $15.7M | Buy |
96,885
+2,348
| +2% | +$379K | 0.4% | 52 |
|
|
2022
Q3 | $12.7M | Buy |
94,537
+2,259
| +2% | +$303K | 0.34% | 70 |
|
|
2022
Q2 | $14.1M | Sell |
92,278
-2,186
| -2% | -$335K | 0.36% | 62 |
|
|
2022
Q1 | $15.3M | Sell |
94,464
-1,717
| -2% | -$278K | 0.33% | 68 |
|
|
2021
Q4 | $13M | Buy |
+96,181
| New | +$13M | 0.26% | 104 |
|